Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database by LaurenEBS | Sep 13, 2023
A Phase II, Open-Label Study of an Accelerated Infusion Rate of Daratumumab in Patients with Relapsed and Refractory Multiple Myeloma by LaurenEBS | Jul 13, 2023
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis by LaurenEBS | Jul 13, 2023
Real-world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database by LaurenEBS | Feb 13, 2023
Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database by LaurenEBS | Aug 13, 2022
